Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients.

van der Meer MG, Cramer MJ, van der Graaf Y, Appelman Y, Doevendans PA, Nathoe HM; SMART Study Group.

Eur J Clin Invest. 2014;44(3):231-9. doi: 10.1111/eci.12222. Epub 2013 Dec 27.

PMID:
24372467
2.

Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.

Subherwal S, Bhatt DL, Li S, Wang TY, Thomas L, Alexander KP, Patel MR, Ohman EM, Gibler WB, Peterson ED, Roe MT.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):541-9. doi: 10.1161/CIRCOUTCOMES.111.964379. Epub 2012 Jun 19.

3.

Gender difference in long-term prognosis among patients with cardiovascular disease.

van der Meer MG, Cramer MJ, van der Graaf Y, Doevendans PA, Nathoe HM; (on behalf of the SMART study group).

Eur J Prev Cardiol. 2014 Jan;21(1):81-9. doi: 10.1177/2047487312460519. Epub 2012 Sep 5.

PMID:
22952288
4.

Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: an observation from the CREDO-Kyoto Registry Cohort-2.

Morikami Y, Natsuaki M, Morimoto T, Ono K, Nakagawa Y, Furukawa Y, Sakata R, Aota M, Okada Y, Onoe M, Kawasuji M, Koshiji T, Nakajima H, Nishizawa J, Yamanaka K, Yamamoto H, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators.

Atherosclerosis. 2013 Jun;228(2):426-31. doi: 10.1016/j.atherosclerosis.2013.04.005. Epub 2013 Apr 18.

PMID:
23623262
5.

Coronary revascularization induces a shift from cardiac toward noncardiac mortality without improving survival in vascular surgery patients.

Ultee KH, Rouwet EV, Hoeks SE, van Lier F, Bastos Gonçalves F, Boersma E, Stolker RJ, Verhagen HJ.

J Vasc Surg. 2015 Jun;61(6):1543-9.e1. doi: 10.1016/j.jvs.2015.01.033. Epub 2015 Mar 11.

PMID:
25769388
6.

Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).

Girasis C, Farooq V, Diletti R, Muramatsu T, Bourantas CV, Onuma Y, Holmes DR, Feldman TE, Morel MA, van Es GA, Dawkins KD, Morice MC, Serruys PW.

JACC Cardiovasc Interv. 2013 Dec;6(12):1250-60. doi: 10.1016/j.jcin.2013.08.009.

7.

Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention.

Miura T, Soga Y, Doijiri T, Aihara H, Yokoi H, Iwabuchi M, Nobuyoshi M.

Circ J. 2013;77(1):89-95. Epub 2012 Sep 26.

8.

Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses.

Tomai F, Pesarini G, Castriota F, Reimers B, De Luca L, De Persio G, Spartà D, Aurigemma C, Pacchioni A, Spagnolo B, Cremonesi A, Ribichini F; Finalized Research in Endovascular Strategies Study Group.

JACC Cardiovasc Interv. 2011 May;4(5):560-8. doi: 10.1016/j.jcin.2011.01.012.

9.

Preoperative percutaneous coronary intervention in patients undergoing open thoracoabdominal and descending thoracic aneurysm repair.

Girardi LN, Rabotnikov Y, Avgerinos DV.

J Thorac Cardiovasc Surg. 2014 Jan;147(1):163-8. doi: 10.1016/j.jtcvs.2013.09.008. Epub 2013 Oct 28.

10.

Long term prognostic value of subclinical carotid and femoral arterial wall lesions in patients with ST-elevation-myocardial infarction having percutaneous coronary intervention.

Monopoli DE, Bertelli L, Sgura FA, Politi L, Becirovic M, Iaccarino D, Lattanzi A, Rampino K, Gorlato G, Menozzi M, Zennaro RG, Rossi R.

Am J Cardiol. 2013 Mar 1;111(5):649-56. doi: 10.1016/j.amjcard.2012.11.014. Epub 2012 Dec 13. Erratum in: Am J Cardiol. 2013 May 1;111(9):1375. Modena, Maria Grazia [removed].

PMID:
23246270
11.

Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?

Mamas MA, Ratib K, Routledge H, Neyses L, Fraser DG, de Belder M, Ludman PF, Nolan J; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

JACC Cardiovasc Interv. 2013 Jul;6(7):698-706. doi: 10.1016/j.jcin.2013.03.011. Epub 2013 Jun 14.

12.

Cardiovascular events in patients with atherothrombotic disease: a population-based longitudinal study in Taiwan.

Lee WH, Hsu PC, Chu CY, Su HM, Lee CS, Yen HW, Lin TH, Voon WC, Lai WT, Sheu SH.

PLoS One. 2014 Mar 19;9(3):e92577. doi: 10.1371/journal.pone.0092577. eCollection 2014.

13.

Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of ≥70 years.

Alam M, Virani SS, Shahzad SA, Siddiqui S, Siddiqui KH, Mumtaz SA, Kleiman NS, Coselli JS, Lakkis NM, Jneid H.

Am J Cardiol. 2013 Sep 1;112(5):615-22. doi: 10.1016/j.amjcard.2013.04.034. Epub 2013 May 29.

PMID:
23726179
14.

Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention.

Pereg D, Elis A, Neuman Y, Mosseri M, Segev D, Granek-Catarivas M, Lishner M, Hermoni D.

Coron Artery Dis. 2014 Jan;25(1):79-82. doi: 10.1097/MCA.0000000000000044.

PMID:
24128887
15.

Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease.

Welten GM, Schouten O, Hoeks SE, Chonchol M, Vidakovic R, van Domburg RT, Bax JJ, van Sambeek MR, Poldermans D.

J Am Coll Cardiol. 2008 Apr 22;51(16):1588-96. doi: 10.1016/j.jacc.2007.11.077.

16.

Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents.

Pilgrim T, Kalesan B, Zanchin T, Pulver C, Jung S, Mattle H, Carrel T, Moschovitis A, Stortecky S, Wenaweser P, Stefanini GG, Räber L, Meier B, Jüni P, Windecker S.

EuroIntervention. 2013 Jan 22;8(9):1061-71. doi: 10.4244/EIJV8I9A163.

17.

Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.

Davies WR, Brown AJ, Watson W, McCormick LM, West NE, Dutka DP, Hoole SP.

Circ Cardiovasc Interv. 2013 Jun;6(3):246-51. doi: 10.1161/CIRCINTERVENTIONS.112.000184. Epub 2013 May 21.

18.

Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial).

Mercado N, Brugts JJ, Ix JH, Shlipak MG, Dixon SR, Gersh BJ, Lemos PA, Guarneri M, Teirstein PS, Wijns W, Serruys PW, Boersma E, O'Neill WW.

Am J Cardiol. 2008 Nov 1;102(9):1151-5. doi: 10.1016/j.amjcard.2008.06.035. Epub 2008 Aug 9.

PMID:
18940282
19.

Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.

JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.

20.

Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.

Rezende PC, Hueb W, Garzillo CL, Lima EG, Hueb AC, Ramires JA, Kalil Filho R.

J Thorac Cardiovasc Surg. 2013 Nov;146(5):1105-12. doi: 10.1016/j.jtcvs.2012.08.015. Epub 2012 Aug 31.

Items per page

Supplemental Content

Write to the Help Desk